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a  b  s  t  r  a  c  t
The  prevalence  of  obesity  is  increasing  worldwide  with  serious  consequences  such  as  diabetes  mellitus
type  2  and  cardiovascular  diseases.  Emotional  stress  is considered  to be  one  of the  main  reasons  of  obesity
development  in  humans.  However,  there  are some  contradictory  results,  which  should  be addressed.
First  of  all  stress  induces  anorexia,  but  not  overeating  in laboratory  animals.  Glucocorticoids,  the  effector
molecules  of  the  hypothalamo-pituitary-adrenocortical  (HPA)  axis  stimulate  and  stress  inhibits  food
intake.  It is  also  not  clear if stress  is  diabetogenic  or  an  antidiabetogenic  factor.  The  review will discusseseywords:
tress
RH
CTH
lucocorticoid
ood intake regulation
these  issues  and  the  involvement  of the  whole  HPA  axis and  its separate  molecules  (glucocorticoids,
adrenocorticotropin,  corticotropin-releasing  hormone)  in  food  intake  regulation  under  stress.
© 2013 Published by Elsevier Inc.besity
ontents
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. Introduction
The prevalence of obesity is increasing worldwide with serious
onsequences such as diabetes mellitus type 2 (DM2) and cardio-
ascular diseases (Caballero, 2007). At the same time people in the
eveloped countries are facing more stress, which might be one of
he contributing factors for the development of obesity (Adam and
pel, 2007; Greeno and Wing, 1994; Nieuwenhuizen and Rutters,
008; O’Connor and Conner, 2011). However, the stress-eating-
besity relationship is complicated (Moore and Cunningham,
012). First of all, among experimental conditions stress induces
norexia, while in humans stress-induced obesity is more preva-
ent. In line with these observation glucocorticoids (GCs), the
ffector molecules of the hypothalamo-pituitary-adrenocortical
xis (HPA or stress axis, Fig. 1) stimulate (Bartolomucci et al., 2009;
jorntorp, 2001; King and Smith, 1985), while stress, as a whole,
nhibits food intake (Bazhan et al., 2007; De Souza et al., 2000;
arris et al., 2001; Krahn et al., 1990; Rybkin et al., 1997). It is also
ot clear if stress is diabetogenic (Rosmond, 2003; Surwit et al.,
992) or an antidiabetogenic factor (Bates et al., 2008a,b; Kai et al.,
000).
Although GCs are the end hormones of the HPA axis, we
ssume that other components of the axis could also have a
ole in food intake regulation during stress (Fig. 1). Of course
ther systems could have been taken into consideration, like
he stress-induced increase in sympatho-adrenomedullary activ-
ty or the serotoninergic system, but in our minireview we  will
ocus on the molecules of the HPA axis. In the following we  will
ummarize participation of stress, its end hormone (GCs), hypophy-
eal (adrenocorticotropin, ACTH) and hypothalamic components
corticotropin-releasing hormone, CRH) in food intake regulation,
hich is one of the crucial components of obesity.
. StressPlease cite this article in press as: Bazhan, N., Zelena, D., Food-intake regul
Res.  Bull. (2013), http://dx.doi.org/10.1016/j.brainresbull.2013.04.002
CRH, originally characterized in the nucleus paraventricularis
ypothalami (PVN) as the principal regulator of the HPA axis,
as broad central and peripheral distribution and actions. CRH-1
ig. 1. Possible contribution of the molecules of the hypothalamo-pituitary-
drenocortical axis to food intake regulation. Stress per se is anorexigenic. However,
n  combination with comfort food it might induce obesity. In this respect gluco-
orticoids are very important. They exert orexigenic effect among rest, but the
norexigenic factors may  overcome their effect during stress. However, in the pres-
nce of high calorie diet the addictive potential of glucocorticoid may come into
ighlight and strongly contribute to development of obesity. CRH, corticotropin-
eleasing hormone; ACTH, adrenocorticotropin; GCs, glucocorticoids.
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and CRH-2 receptors relay signals from CRH and its paralogues
urocortins (Ucn) (Kuperman and Chen, 2008). CRH-1 receptor is
expressed on anterior pituitary corticotropes and induces the syn-
thesis of ACTH from proopiomelanocortin (POMC) precursor in
response to hypothalamic CRH (Vale et al., 1981). This release
leads to the downstream secretion of GCs from the adrenal cor-
tex via melanocortin 2 (MC-2) receptors. The endhormones of the
axis, GCs have widespread effects through ubiquitous intracellu-
lar glucocorticoid receptor (GR), which could be found on most
cells and tissues, and through another intracellular steroid receptor,
the mineralocorticoid receptor (MR), which is more abundant in
the hippocampus and regulates negative feedback on the HPA axis
(Chrousos, 2000). Among others GCs stimulate the gluconeogenesis
in the liver to increase circulating glucose levels.
There are several studies on the effect of stress on food-intake
without dissecting a single molecule. Thus, in these cases we  might
assume the involvement of the molecules of the whole HPA axis,
not only GCs, but also ACTH and CRH.
2.1. Stress-induced anorexia
Emotional stress is known to suppress appetite in humans (Fryer
et al., 1997) and laboratory rodents (Bazhan et al., 2007; De Souza
et al., 2000; Harris et al., 2001; Krahn et al., 1990; Rybkin et al.,
1997) (Table 1 and Fig. 1). The stress-induced reduction in food
intake has been demonstrated both as an acute response after a
single stress and as a maintained decrease in 24 h food intake during
and after repeated daily restraint stress (Krahn et al., 1990; Shimizu
et al., 1989). Moreover, once stress has ended, restrained rats fail
to return to normal weight (Bazhan et al., 2007; Levin et al., 2000;
Rybkin et al., 1997).
Central mechanisms involved in the stress-induced inhibition
of food intake have not been fully elucidated, but certain brain
areas were already suggested to have a role. The major central
nervous system structure involved in food-intake regulation is the
hypothalamus (especially the ventromedial hypothalamus (VMH),
lateral hypothalamus, PVN and nucleus arcuatus (ARC)) (Palkovits,
2003; Schwartz et al., 2000) being the center of stress response,
too. Indeed, hypothalamic CRH and melanocortin systems are
well recognized to connect stress with anorexia in rodents (Ohata
and Shibasaki, 2011). CRH system is a mediator of the appetite-
suppressing effects of stress also in ﬁsh (Bernier, 2006).
Other brain areas, like amygdala (Holsen et al., 2012; Solomon
et al., 2010), dorsal vagal complex (Charrier et al., 2006) and dor-
sal raphe (Holsen et al., 2012), may  contribute to stress-induced
anorexia without affecting the HPA axis activity.
2.2. Stress-induced comfort food eating
Anorexia induced by acute and repeated restraint stress was fol-
lowed by increased proportion of comfort food eating (with high
fat/sugar contents) (Dallman, 2010; Dallman et al., 2005; Foster
et al., 2009; la Fleur et al., 2005; Pecoraro et al., 2004). In contrast
to normal diet, when sweet food was presented to the stressed
animals repeated mild pinch resulted in hyperphagia and consid-
erable gain in body weight (Rowland and Antelman, 1976) (Table 1).
Chronic life stress seems to be associated with a greater preference
for energy- and nutrient-dense foods (Torres and Nowson, 2007).
During the course of prolonged/repeated food intake the sensory-
speciﬁc satiety (SSS) can reduce the intake of the same food.
Stressors may  induce a disruption of this signal, thereby resulting
in a relative increase in consumption of the same food (Ahn andation during stress by the hypothalamo-pituitary-adrenal axis. Brain
Phillips, 2012). Comfort food per se might have similar effect. E.g. in
an unstressed human population habituation could develop to SSS
effect of the same, although palatable diet (Tey et al., 2012). Devel-
opment of obesity to monotonous high fat diet in animals (DIO
134
135
136
137
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Table  1
Effects of stress on the food intake.Q4
High calorie food Is not available Is available
Food intake Anorexia (Bazhan et al., 2007; De Souza et al., 2000; Fryer et al.,
1997; Harris et al., 2001; Krahn et al., 1990; Rybkin et al., 1997)
Hyperphagia (Dallman, 2010; Dallman et al., 2005; Foster et al.,
2009; la Fleur et al., 2005; Pecoraro et al., 2004)
Mechanisms Stress induces anorexia due to decreased signaling of:
AgRP (Chagra et al., 2011; Kas et al., 2005)
NPY (Tempel and Leibowitz, 1994; White, 1993)
due to increased signaling of:
insulin? (Chavez et al., 1997; Warne, 2009)
leptin? (Dagogo-Jack et al., 1997; Miell et al., 1996; Newcomer
et al., 1998; Slieker et al., 1996; York, 1996)
CRH and Ucn 3 (Bernier, 2006; Ohata and Shibasaki, 2011; Smagin
et  al., 1998)
CART (Kask et al., 2000; Xu et al., 2010)
Nesfatin-1 (Goebel et al., 2009; Stengel et al., 2011)
NPW (Beck et al., 2010)
Melanocortins (Liu et al., 2007; Yamano et al., 2004)
central monoaminergic systems (Gibson, 2006)
autonomous nervous system (Seematter et al., 2004)
Stress induces hyperphagia due to reduction of:
sensor speciﬁc satiety (Ahn and Phillips, 2012; Ortolani et al., 2011)
stressor aversiveness (Piazza and Le Moal, 1997)
CRH signaling? (Foster et al., 2009; la Fleur et al., 2005; Pecoraro
et  al., 2004)
due to activation of central reward pathways (Piazza and Le Moal,
1997),
due to alterations in gut microbiota (Tehrani et al., 2012)
Glucocorticoids induce hyperphagia (Dallman, 1993; Drapeau et al.,
2003; Epel et al., 2000; Tataranni et al., 1996)
due to increased signaling of:
NPY (Gyengesi et al., 2010; Krysiak et al., 1999; McKibbin et al.,
1992; White et al., 1994; Wilding et al., 1993),
AgRP (Coll et al., 2005; Savontaus et al., 2002),
Nociceptin (Green and Devine, 2009; Nativio et al., 2011;
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217gRP, agouti related peptide; NPY, neuropeptide Y; CRH, corticotrophin-releasing 
eptide W.
odel) suggests a similar habituation to the SSS effect in rodents
Auvinen et al., 2011; Ryan et al., 2012). Moreover, rats submitted
o footshock stress decreased the intake of commercial chow, but
ept unaltered the intake of comfort food (Ortolani et al., 2011).
According to Dallman, energy stores are critically impor-
ant for normal activity in the central stress–response network
Dallman, 2010). When a chronic stressor results in high GCs lev-
ls, the steroids act in brain in a feed-forward fashion to recruit
 stress–response network that biases ongoing autonomic, neu-
oendocrine, and behavioral outﬂow as well as responses to novel
tressors (Dallman et al., 2006). When rats are allowed to eat fat
r sucrose under acute or repeated restraint stress, CRH expression
n the hypothalamus and bed nucleus of stria terminalis (BNST), as
ell as ACTH and GC secretion are reduced (Foster et al., 2009; la
leur et al., 2005; Ortolani et al., 2011; Pecoraro et al., 2004).
On the other hand, increased ingestion of palatable foods
uring and after stressors may  simply reﬂect a pleasurable activ-
ty that reduces the discomfort of stress. Eating a meal alters
ood and emotional predisposition, typically reducing arousal and
rritability, and increasing calmness and positive affect (Gibson,
006). Since food intake has reinforcing effects, we  can assume that
evere obesity and addiction disorders share, at least in parts, com-
on  neuronal circuits (Berridge, 2009; Kiefer and Grosshans, 2009;
olkow et al., 2008). Indeed, eating of high calorie food is known
o counteract some effects of stress, probably via the same mech-
nism as in alcoholics (Kiefer and Grosshans, 2009). Chronic stress
as been known to potentiate addictive behaviors in both human
ddicts and experimental animals (Stamp et al., 2008). By stimu-
ating central reward pathways, high levels of corticosterone (the
ain GC in rodents) can reduce the aversiveness of the stressor
Piazza and Le Moal, 1997).
Another possible mechanism, how stress can affect obesity is the
idirectional interaction between HPA axis and the gastrointesti-
al tract (Dinan and Cryan, 2012; Sudo, 2012). Stressor exposure
nduces negative changes in several gastrointestinal parameters
ncluding microbiota (Konturek et al., 2011). Alteration in gut
icrobiota may  be an initial event leading to altered feeding behav-
or than to weight gain and metabolic syndrome (Tehrani et al.,
012). High-calorie diet has been also associated with changes in
he gut microbiota in mice and in humans, thus stressor-inducedPlease cite this article in press as: Bazhan, N., Zelena, D., Food-intake regul
Res.  Bull. (2013), http://dx.doi.org/10.1016/j.brainresbull.2013.04.002
omfort food intake can induce obesity also through an inﬂuence
n microbiome (Pedersen et al., 2013).
Taken together, the scheme proposed by Dallman is very sim-
le: stress induces comfort food eating and comfort food eatingOlszewski and Levine, 2004);
one; Ucn+, urocortin 3; CART, cocain-amphetamine related peptide; NPW, neuro-
reduces stress (Dallman et al., 2005). Although we should take
into consideration the rewarding nature of meal, Dallman’s theory
on the stress-induced palatable eating is of great importance for
understanding mechanisms of obesity development. However, it
concerns only human, since animals cannot prefer “palatable food”
in the wild nature. Despite the more prevalent stress-induced obe-
sity in human, there is no animal model, where single or repeated
stress exposure leads to development of obesity under normal diet.
GCs may  potentiate the development of obesity and other aspects
of metabolic syndrome only in those animals, which fed a high calo-
rie, fat or sugar diet during the stress (Rasmusson et al., 2010). Thus,
stress per se, without high calorie input does not result in obesity.
Although this idea is not really new, but should be emphasized since
changes in eating behavior seem to be an essential tool in the ﬁght
against obesity.
2.3. Stress and glucose metabolism
It is well known that acute stress induces temporary elevation
in blood glucose levels, although this acute increase maybe due
mostly to sympathetic activation (Seematter et al., 2000). Never-
theless, a rise in peripheral blood glucose concentration inhibits
the appetite (Blazquez Fernandez, 2003; Burdakov et al., 2005).
On the other hand, prolonged stress-induced excess of GCs may
lead to hyperphagia (Drapeau et al., 2003), thereby to obesity and
insulin resistance together with hyperglycaemia leading to devel-
opment of DM2  (Rosmond, 2003; Surwit et al., 1992). In this case the
hypophagic effect of high glucose levels cannot be detected as the
insulin resistance prevents glucose action on the neurons involved
in the food intake regulation.
On the contrary, adaptation to intermittent restraint stress
(Bates et al., 2008a,b) and immobilization (Kai et al., 2000) delays
development of hyperglycemia and hyperinsulinemia (Bazhan
et al., 2007) in rodent genetic models of DM2. It is partially due
to stress-induced anorexia that likely improves insulin sensitivity
and maintains -cell compensation (Bates et al., 2008a,b; Kelley
et al., 1993). Another possible mechanism is the intermittent stress-
induced adaptations that reduce the hyperglycemic effect of GCsation during stress by the hypothalamo-pituitary-adrenal axis. Brain
(Bates et al., 2008a,b).
Importantly, these later ﬁndings contrast with common view
that all stressors are deleterious for diabetes and illustrate that
intermittent exposure to stressors and the ensuing adaptations
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ay  instead be important for normal physiological functioning by
reparing the body to deal with threats to homeostasis.
. Glucocorticoids
Although there are many functions related to GCs from permis-
ive one till stimulations (Sapolsky et al., 2000), but till now we do
ot know what is the exact role of stress-induced elevation of GCs
Vinson, 2009). Perhaps the ﬁrst described role, the regulation of
he blood glucose levels is the most important one. GCs stimulate
lucose output from the liver by inducing gluconeogenic enzymes
nd by mediating, through their metabolic action on muscle, the
rovision of the gluconeogenic substrate.
Since abdominal adipose tissue has more cells per mass units,
igher blood ﬂow and more GC receptors, GCs affect abdominal
at to a greater extent than subcutaneous adipose tissue (Drapeau
t al., 2003). Therefore it is likely that some types of abdomi-
al obesity may  be due to increased GC access (Dallman et al.,
995). Cushing’s syndrome is the best evidence. A mutation of the
orticosterone-binding globulin with increased free GC levels has
een also associated with a higher waist-to-hip ratio and a higher
isk on obesity development (Barat et al., 2005; Joyner et al., 2003).
he abdominal obesity is specially important as obese with a more
eripheral body fat distribution does not show health risk markers
Nieuwenhuizen and Rutters, 2008).
Under normal physiological conditions, endogenous GCs may
ave a primary function in controlling nutrient ingestion and
etabolism over the natural circadian cycle (Tempel and Leibowitz,
994). Low basal levels of circulating corticosterone tonically acti-
ate MRs  leading to fat ingestion and deposition. In contrast, GRs
re phasically activated during the circadian or stressor-induced
eak of GCs. Activation of this receptor is required for carbohydrate
ngestion which provides additional substrate for glucose homeo-
tasis thereby ensuring energy to stress. Through these actions GCs
ave impact on total calorie intake and on long-term regulation
f body weight. There are many polymorphisms both of GR and
R with enhanced GC effects, which are associated with obesity
Nieuwenhuizen and Rutters, 2008).
.1. Central orexigenic effects
Although GCs are primarily catabolic at the periphery (lipol-
sis, proteolysis, but glycogenesis), they have anabolic effects in
he central nervous system (CNS) (Dallman et al., 1995), where
hey act to increase food intake (Drapeau et al., 2003; Tempel
t al., 1992) (Fig. 1). Appetite in humans and animals follows
hanges in adrenal steroid levels. Anorexia and weight loss are
allmarks of adrenal insufﬁciency in Addison’s disease, whereas
ncreased appetite correlates with GC overproduction in Cush-
ng’s syndrome and with exogenous GC administration in normal
olunteers (Tataranni et al., 1996). In women experimental stress-
nduced cortisol secretion increased appetite and craving for sugar
Epel et al., 2000). Adrenalectomy (ADX, surgical removal of the
drenals) or GC treatment, respectively, prevent or restore weight
ain in both normal rodents and many models of genetic or exper-
mentally induced obesity, often through an effect on food intake
Dallman, 1993; Jacobson, 1999; Santana et al., 1995; Tokuyama
nd Himms-Hagen, 1989).
Besides a possible direct effect GCs may  promote food
onsumption through stimulation of orexigenic hypothalamic neu-
opeptides like neuropeptide Y (NPY) and agouti related peptidePlease cite this article in press as: Bazhan, N., Zelena, D., Food-intake regul
Res.  Bull. (2013), http://dx.doi.org/10.1016/j.brainresbull.2013.04.002
AgRP) (Gyengesi et al., 2010) (Table 1). ADX reduces the number of
xcitatory synapses onto NPY/AgRP neurons (Gyengesi et al., 2010),
nd decreases NPY and AgRP gene expressions in the medial basal
ypothalamus in rats (Savontaus et al., 2002). All of these changes PRESS
h Bulletin xxx (2013) xxx– xxx
were reversed by GC replacement (Gyengesi et al., 2010). In addi-
tion, GCs produce an increase of NPY mRNA and protein in the ARC
(Wilding et al., 1993) and in PVN (Krysiak et al., 1999; McKibbin
et al., 1992) in rats. Different stressors such as brief session of
inescapable foot shocks and 1-h restraint increase NPY mRNA levels
in the ARC of rats (Conrad and McEwen, 2000; Kas et al., 2005).
Nociceptin/orphanin, a peptide closely related to dynorphin
A, moderately increases food intake under various conditions
(Olszewski and Levine, 2004). Both stress (restraint) and GC admin-
istration increase the level of nociceptin in the hippocampus
(Nativio et al., 2011). Stress induced by social defeat elevated the
mRNA level of nociceptin receptor in the PVN (Green and Devine,
2009).
On the other hand, GCs may  inhibit the release of the anorex-
igenic signals like CRH (Foster et al., 2009; la Fleur et al., 2005;
Pecoraro et al., 2004). The picture is even more complicated as it was
proposed that GCs increased orexigenic hypothalamic NPY concen-
trations and NPY gene expression via both direct mechanisms and
indirectly through inhibition of the CRH system (Cavagnini et al.,
2000). However, genetic CRH deﬁciency neither augmented basal
food intake nor attenuated decreases in feeding after ADX, further-
more, restoration of food intake in ADX mice by GCs did not depend
on inhibition of CRH (Jacobson, 1999). These results suggest that,
at least in mice, factors other than or in addition to CRH are more
important for controlling basal and GC associated effects on food
intake.
3.2. Central anorexigenic effect
Our assumption is that primary effect of GCs is orexigenic and
anorexigenic effects are secondary. However, the orexigen effect
of GCs is expressed only in nonstress conditions, as during stress
inhibition of food intake obscures it, despite the dramatically high
plasma GC concentrations (Bazhan et al., 2007; De Souza et al.,
2000; Harris et al., 2001; Krahn et al., 1990; Rybkin et al., 1997). It is
not entirely clear, what shifts the behavioral outcome of orexigenic
GC administration to anorexigenic stress-induced GC elevation.
One possible target could be the NPY/AgRP neurons. Although
GC administration stimulates both orexigenic neuropeptides (see
earlier), but during stressful events their expressions are differ-
entially regulated (Kas et al., 2005). More precisely, acute and
repeated restraint reduces the number of AgRP-expressing cells
(Chagra et al., 2011), and brief session of inescapable foot shocks
down-regulates AgRP mRNA levels in ARC in the rat hypothala-
mus  (Kas et al., 2005). AgRP is known to be the natural antagonist
for the type 4 melanocortin (MC-4) receptors mediating anorex-
igenic signals of melanocortins (Leibowitz and Wortley, 2004).
Stress-induced reduction in AgRP expression may  contribute to
food intake inhibition through activation of melanocortin signaling.
Indeed, melanocortinergic pathway can be rapidly recruited by
acute emotional stress (Liu et al., 2007).
Previous studies considered the elevation of insulin as the
most important anorexigenic factor during stress. It is known that
exogenous GCs stimulate insulin production in ADX rats (Warne,
2009) and ADX increases sensitivity to the effect of central insulin
administration to reduce food intake (Chavez et al., 1997). How-
ever, we  should mention, that restraint stress does not increase,
but decreases insulin levels (Kiba, 2004; Macho et al., 1999;
Nonogaki, 2000). Moreover, stressors-induced adrenal epinephrine
and sympathetic norepinephrine release is known to inhibit insulin
secretion (Kiba, 2004; Nonogaki, 2000). Therefore other mecha-
nisms should be considered.ation during stress by the hypothalamo-pituitary-adrenal axis. Brain
An elevation in plasma leptin levels is also anorexigenic
(Ortolani et al., 2011; Won  et al., 2009; Zareian et al., 2011). GCs can
interact with leptin in the long-term regulation of energy intake and
body adiposity. For example, hyperphagia in animals with leptin
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r leptin receptor deﬁciency is attenuated by ADX (York, 1996),
upraphysiological doses of exogenous GCs increase leptin mRNA
evels in ob/ob mice, leptin secretion in cultured rat adipocytes
Slieker et al., 1996), and circulating leptin concentrations in nor-
al  and obese humans (Dagogo-Jack et al., 1997; Miell et al., 1996;
ewcomer et al., 1998). But these authors did not measure food
ntake, and it remains unknown whether GC-induced hyperleptine-
ia  is followed by anorexia in humans. Moreover, acute elevation
f plasma GCs, in a physiological range, induced with central phar-
acological or physiological stimuli (stress, naloxone, vasopressin
nd/or CRH) does not appear to inﬂuence plasma leptin concentra-
ions in humans (Nye et al., 2000; Tataranni et al., 1997) and adipose
eptin gene expression in rats (Rybkin et al., 1997). Thus, further
tudies are required to determine whether GCs can inhibit food
ntake during stress by stimulating plasma leptin levels (Leal-Cerro
t al., 2001).
We assume that orexigenic effects of GCs are not expressed
n response to acute and chronic stresses in laboratory rodents,
ecause they are counteracted by other stress-induced anorexi-
enic mechanisms, which are not dependent on the increased GC
evels, e.g. melanocortin system, CRH and Ucn 3 signaling (Bernier,
006; Ohata and Shibasaki, 2011; Smagin et al., 1998), cocaine-
nd amphetamine-regulated transcript (CART) (Kask et al., 2000;
u et al., 2010), nesfatin-1 (Goebel et al., 2009; Stengel et al., 2011),
europeptide W (NPW) (Beck et al., 2010), melanocortins (Liu et al.,
007; Yamano et al., 2004) and others, but the exact mechanism is
ot clear (Table 1).
. Adrenocorticotropin
The importance as well as the bimodal effect of ACTH in obesity
s demonstrated by the fact that autoantibodies against ACTH could
e found in 74% of patients both with anorexia nervosa and bulemia
ervosa (Fetissov et al., 2002). Moreover, a rare mutation in exon 2
f POMC, that causes ACTH insufﬁciency, has been associated with
arly-onset obesity (Krude et al., 1998). There is no information
vailable concerning the involvement of pituitary and peripheral
CTH on the central mechanisms of food-intake regulation, but
elated effects could be detected at the periphery.
.1. Metabolic effects
In normal animals injection of ACTH increased both plasma glu-
ose and insulin levels. In contrast, in adrenalectomised rabbits
CTH administration further increased the ADX-induced insu-
inemia along with hypoglycemia. Therefore it is reasonable
o conclude that ACTH through GCs increases glucose levels,
hile, through stimulation of the pancreatic secretion of insulin,
ecreases it (Lesault et al., 1991).
ACTH may  increase local blood ﬂow in the brown adipose tissue
nﬂuencing fat metabolism (Kuroshima et al., 1968). Indeed, MC-
 receptors are expressed in white and brown adipocytes both at
he mRNA and protein levels (Iwen et al., 2008) and ACTH stimu-
ates free fatty acid release from epigastric adipose tissue of rabbits
Lewis and Matthews, 1968). Thus, ACTH has a direct lipolytic activ-
ty – present also in ADX rats – however, this effect is substantially
ower than that of GCs (Spirovski et al., 1975). Insulin-induced glu-
ose uptake in white adipocytes is reduced by ACTH treatment,
hereby here not only the indirect (through GCs), but also the direct
ffect of ACTH is antagonistic to insulin. Thus, ACTH directly pro-Please cite this article in press as: Bazhan, N., Zelena, D., Food-intake regul
Res.  Bull. (2013), http://dx.doi.org/10.1016/j.brainresbull.2013.04.002
otes insulin-resistance and enhances energy combustion. Taken
ogether, the ACTH–adipocyte interaction may  contribute to dys-
egulated energy balance, insulin resistance and cardio-metabolic
omplications in obesity and metabolic syndrome, however this
ssumption is not fully conﬁrmed, yet.
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4.2. Behavior
In the hypothalamus, proopiomelanocortin (POMC)-derived
peptides, -MSH and ACTH, play a central role in the regulation
of food intake via MC-4 receptor (Gantz et al., 1993). A potential
role for ACTH in energy homeostasis is supported by observations
that ACTH has a similar potency to -MSH at the MC-4 receptor
in vitro (Gantz et al., 1993), ACTH is secreted by the neurons of
PVN (Pritchard et al., 2003), and ACTH can inhibit feeding when
administered centrally to rats (Al-Barazanji et al., 2001). Single and
repeated injections of ACTH antibodies into PVN resulted in per-
sistently increased food intake during the light period. These data
demonstrate extra-hormonal effects of ACTH and provide evidence
that endogenous ACTH without further processing acts in the PVN
to reduce food intake (Schulz et al., 2010).
Some data indicate that acute stressors stimulate melanocortin
signaling, e.g. electrical shock increases MC-4 receptor and POMC
mRNA, restraint and forced swimming evoke neuronal activation
of POMC neurons in rat and mouse hypothalamus (Liu et al., 2007;
Yamano et al., 2004). These data suggest the possible involvement
of the hypothalamic melanocortins, including ACTH, in the devel-
opment of stress-induced anorexia.
5. Corticotropin-releasing hormone
It is generally accepted that decreased feeding in response to
stress reﬂects an adaptive, defensive anorexia. Several investigators
have attributed stressor-induced anorexia to activation of the CRH-
system. It is well established that CRH inﬂuences feeding behavior
and mediates behavioral and physiological responses to stress not
only in laboratory rodents (Krahn and Gosnell, 1989), but also in
steeres (Yayou et al., 2011) and ﬁshes (Kang et al., 2011). Intra-
cerebroventricular administration of CRH in rats inhibits feeding
behavior (Cullen et al., 2001). Chronic administration of CRH into
the hypothalamus also decreases food intake and body weight gain
in rats (Tempel and Leibowitz, 1994). Pharmacological activation
of the hypothalamic CRH-2 receptors results also in suppression of
feeding (Fekete and Zorrilla, 2007). At this point Ucn1 and Ucn 3, the
main ligands of these receptors, may also have a role (Kuperman
et al., 2010).
5.1. Brain targets
The level of CRH is elevated in response to stress not only in
the PVN, but also in many brain areas involved in the regulation
of feeding behavior. E.g. the VMH  is classically referred to as the
satiety center because its electrical stimulation leads to inhibi-
tion of food intake. CRH-2 receptor mRNA has been demonstrated
to be highly expressed here (Lovenberg et al., 1995). Basolateral
amygdala mediates CRH-induced anorexia through CRH-1 recep-
tors (Jochman et al., 2005), while lateral septum and BNST through
the CRH-2 receptor (Ohata and Shibasaki, 2011; Smagin et al.,
1998). However, pharmacological and neuromorphological studies
have demonstrated that Ucn-3 rather than CRH is the most potent
and speciﬁc endogenous ligand for CRH-2 receptor (Chen et al.,
2010). In rats Ucn-3, injected into the VMH, signiﬁcantly reduced
the food intake without affecting the HPA axis activity (Chen et al.,
2010; Kuperman and Chen, 2008).
Nevertheless, knocking out the CRH-1 or CRH-2 receptor does
not inﬂuence body weight or basal food intake (Preil et al., 2001).
Thus, neither CRH receptor is likely to play a critical role in theation during stress by the hypothalamo-pituitary-adrenal axis. Brain
basal regulation of body weight and the total amount of food intake.
Rather, they may  be involved in biphasic control of Ucn-mediated
feeding behavior (Bradbury et al., 2000; Coste et al., 2000), as
well as in cross-talk among central leptin, melanocortin and CRH
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athways (Marsh et al., 1999; Uehara et al., 1998). This assump-
ion is supported by the fact that leptin up-regulates VMH  CRH-2
eceptor mRNA levels (Huang et al., 2006) mediating anorexigenic
ffects of CRH and/or Ucns.
.2. Indirect effects
CRH may  exert orexigenic effect through elevation of plasma
C concentrations. In line with this idea CRH infusion to healthy,
on-obese adults resulted in elevated cortisol levels parallel with
n increase in food-intake (George et al., 2010).
On the other hand, CRH may  interact with orexigenic pep-
ides. CRH inhibits NPY synthesis and release (White, 1993) and
ecreases NPY-induced food intake (Tempel and Leibowitz, 1994).
everal studies indicate that nociceptin/orphanin acts in the BNST
s a functional antagonist of CRH to inhibit its anorexigenic effect
Ciccocioppo et al., 2004).
. Conclusions
In both animals and humans, stress affects food intake in a bidi-
ectional way depending on stress intensity and environmental
actors (Table 1). Any stress activates both anorexigenic and orex-
genic pathways (Fig. 1 and Graphical abstract). Balance between
he pathways shifts to anorexigenic if high calorie food is not avail-
ble (it is not clear how), and shifts to orexigenic if high calorie
ood is available, obviously due to reduced aversiveness of stress
nd rewarding potential of the food. Thus, stress may  potentiate
he development of obesity and other aspects of metabolic syn-
rome only in animals and people, which fed a high calorie, fat and
ugar diet. This is important since behavioral modiﬁcation – do not
at in excess – is likely to have a major epidemiological impact
n the obesity epidemic. In this context stress is diabetogenic only
n combination with a special diet and intermittent stressors are
ather antidiabetogenics, thus beneﬁcial. In human, stress-induced
xcessive GC production leads to search for palatable food because
f its rewarding, stress-reducing potentials.
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